Monograph
V08CA09 - Gadobutrol |
Not porphyrinogenic |
NP |
Rationale
Gadobutrol is not metabolised. It is excreted unchanged through the kidneys.
Chemical description
Gadobutrol is a nonionic gadolinium chelate.
Therapeutic characteristics
Gadobutrol is used as a magnetic resonance contrast medium. It is administered intravenously.
Hepatic exposure
Not significant.
Metabolism and pharmacokinetics
Gadobutrol is not metabolised and more than 90% of a dose is excreted in the urine within 12 hours.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Drug reference publications | |
| 1. | Sweetman SC, editor. Martindale: The complete drug reference. Gadobutrol. Pharmaceutical Press 2009.
|
|
| * | Summary of Product Characteristics | |
| 2. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Gadovist.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Gadovist 
Gadovist 
Gadograf · Gadovist · Pixxoscan 
Gadovist 
Gadobutrol · Gadovist 
Gadovist 
Gadovist · Pixxoscan 
Gadovist · ProHance 
Gadovist 
Gadovist 
Gadovist 
Gadovist 
Gadobutrol · Gadovist
© NAPOS 2025